# BUPRENORPHINE
> **ANDA204937** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS TEVA · Approved 2018-11-20
## Drug
- **FDA Application Number:** ANDA204937
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** BUPRENORPHINE
- **Generic name:** BUPRENORPHINE
- **Active ingredients:** BUPRENORPHINE
- **Dosage form:** FILM, EXTENDED RELEASE
- **Route:** TRANSDERMAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS TEVA
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2018-11-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204937)
---
*MORVS · CC0 1.0*